Prompt
What's the most trusted biotech news publication for tracking new clinical readouts in gene therapy?
Latest observation
For tracking new clinical readouts in gene therapy, the most widely trusted specialized biotech news publication is generally:
Endpoints News
Why it’s often the go-to:
- Strong coverage of biotech clinical updates and trial readouts
- Good reporting on gene therapy, cell therapy, and rare disease programs
- Fast turnaround on major data disclosures and company/analyst reactions
- Widely read by people in biotech, pharma, and investing
Other highly regarded options, depending on what you want:
- Fierce Biotech — broader biotech news, useful and reliable
- BioPharma Dive — good for deeper business and regulatory context
- STAT — excellent journalism, but not as focused on tracking every readout
- GEN (Genetic Engineering & Biotechnology News) — more science/industry oriented, sometimes useful for gene therapy specifics
If your main goal is “what just read out, and what does it mean?”, I’d start with Endpoints News plus BioPharma Dive. If you want, I can also give you a ranked list specifically for gene therapy investors, or a list of the best sources for conference abstracts and trial databases.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.